Literature DB >> 26666660

Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events.

Jamal S Rana1,2,3,4, Jennifer Y Liu5, Howard H Moffet5, Marc Jaffe6, Andrew J Karter5.   

Abstract

BACKGROUND: For more than a decade, the presence of diabetes has been considered a coronary heart disease (CHD) "risk equivalent".
OBJECTIVE: The objective of this study was to revisit the concept of risk equivalence by comparing the risk of subsequent CHD events among individuals with or without history of diabetes or CHD in a large contemporary real-world cohort over a period of 10 years (2002 to 2011).
DESIGN: Population-based prospective cohort analysis. PARTICIPANTS: We studied a cohort of 1,586,061 adult members (ages 30-90 years) of Kaiser Permanente Northern California, an integrated health care delivery system. MAIN MEASUREMENTS: We calculated hazard ratios (HRs) from Cox proportional hazard models for CHD among four fixed cohorts, defined by prevalent (baseline) risk group: no history of diabetes or CHD (None), prior CHD alone (CHD), diabetes alone (DM), and diabetes and prior CHD (DM + CHD). KEY
RESULTS: We observed 80,012 new CHD events over the follow-up period (~10,980,800 person-years). After multivariable adjustment, the HRs (reference: None) for new CHD events were as follows: CHD alone, 2.8 (95% CI, 2.7-2.85); DM alone 1.7 (95% CI, 1.66-1.74); DM + CHD, 3.9 (95% CI, 3.8-4.0). Individuals with diabetes alone had significantly lower risk of CHD across all age and sex strata compared to those with CHD alone (12.2 versus 22.5 per 1000 person-years). The risk of future CHD for patients with a history of either DM or CHD was similar only among those with diabetes of long duration (≥10 years).
CONCLUSIONS: Not all individuals with diabetes should be unconditionally assumed to be a risk equivalent of those with prior CHD.

Entities:  

Keywords:  coronary heart disease; diabetes; epidemiology

Mesh:

Year:  2015        PMID: 26666660      PMCID: PMC4803685          DOI: 10.1007/s11606-015-3556-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  24 in total

1.  The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up.

Authors:  F B Hu; M J Stampfer; C G Solomon; S Liu; W C Willett; F E Speizer; D M Nathan; J E Manson
Journal:  Arch Intern Med       Date:  2001-07-23

2.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

3.  Ethnic disparities in diabetic complications in an insured population.

Authors:  Andrew J Karter; Assiamira Ferrara; Jennifer Y Liu; Howard H Moffet; Lynn M Ackerson; Joe V Selby
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

4.  Diabetes and all-cause and coronary heart disease mortality among US male physicians.

Authors:  P A Lotufo; J M Gaziano; C U Chae; U A Ajani; G Moreno-John; J E Buring; J E Manson
Journal:  Arch Intern Med       Date:  2001-01-22

5.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Authors:  N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh
Journal:  Lancet       Date:  2010-06-26       Impact factor: 202.731

6.  Improved blood pressure control associated with a large-scale hypertension program.

Authors:  Marc G Jaffe; Grace A Lee; Joseph D Young; Stephen Sidney; Alan S Go
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

7.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

8.  Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis.

Authors:  Shaista Malik; Matthew J Budoff; Ronit Katz; Roger S Blumenthal; Alain G Bertoni; Khurram Nasir; Moyses Szklo; R Graham Barr; Nathan D Wong
Journal:  Diabetes Care       Date:  2011-08-15       Impact factor: 19.112

9.  Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE).

Authors:  Andrew J Karter; Dean Schillinger; Alyce S Adams; Howard H Moffet; Jennifer Liu; Nancy E Adler; Alka M Kanaya
Journal:  Diabetes Care       Date:  2012-10-15       Impact factor: 19.112

10.  Economic costs of diabetes in the U.S. in 2012.

Authors: 
Journal:  Diabetes Care       Date:  2013-03-06       Impact factor: 19.112

View more
  43 in total

1.  Capsule Commentary on Rana et al., Diabetes and Prior Coronary Heart Disease Are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events.

Authors:  Tiffany M Powell-Wiley
Journal:  J Gen Intern Med       Date:  2016-04       Impact factor: 5.128

2.  Update on peripheral artery disease: Epidemiology and evidence-based facts.

Authors:  Jun Shu; Gaetano Santulli
Journal:  Atherosclerosis       Date:  2018-05-22       Impact factor: 5.162

3.  Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).

Authors:  Favel L Mondesir; Todd M Brown; Paul Muntner; Raegan W Durant; April P Carson; Monika M Safford; Emily B Levitan
Journal:  Am Heart J       Date:  2016-08-12       Impact factor: 4.749

4.  Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010-2013.

Authors:  David I Feldman; Javier Valero-Elizondo; Joseph A Salami; Jamal S Rana; Oluseye Ogunmoroti; Victor Okunrintemi; Chukwuemeka U Osondu; Erica S Spatz; Salim S Virani; Ron Blankstein; Michael J Blaha; Emir Veledar; Khurram Nasir
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-08-15

Review 5.  Cardiovascular Risk Heterogeneity in Adults with Diabetes: Selective Use of Coronary Artery Calcium in Statin Use Decision-making.

Authors:  Sudipa Sarkar; Olusola A Orimoloye; Caitlin M Nass; Roger S Blumenthal; Seth S Martin
Journal:  J Gen Intern Med       Date:  2019-08-14       Impact factor: 5.128

6.  Prognostic relevance of subclinical coronary and carotid atherosclerosis in a diabetic and nondiabetic asymptomatic population.

Authors:  Andrea Igoren Guaricci; Valentina Lorenzoni; Marco Guglielmo; Saima Mushtaq; Giuseppe Muscogiuri; Filippo Cademartiri; Mark Rabbat; Daniele Andreini; Gaetano Serviddio; Nicola Gaibazzi; Mauro Pepi; Gianluca Pontone
Journal:  Clin Cardiol       Date:  2018-06-13       Impact factor: 2.882

7.  Sex Differences in Coronary Artery Calcium and Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in Adults With Diabetes: The Coronary Calcium Consortium.

Authors:  Nathan D Wong; Amber R Cordola Hsu; Alan Rozanski; Leslee J Shaw; Seamus P Whelton; Matthew J Budoff; Khurram Nasir; Michael D Miedema; John Rumberger; Michael J Blaha; Daniel S Berman
Journal:  Diabetes Care       Date:  2020-08-17       Impact factor: 19.112

8.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

9.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

10.  Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol.

Authors:  Nathan D Wong; Ezra A Amsterdam; Christie Ballantyne; Amit Khera; Khurram Nasir; Peter P Toth
Journal:  Am J Cardiovasc Drugs       Date:  2020-02       Impact factor: 3.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.